Immunity against common virus leveraged against pancreatic cancer

Researchers at the University of California San Diego have discovered a promising new treatment approach for pancreatic cancer, one of the deadliest and most treatment-resistant forms of cancer. The approach leverages the body’s natural immune response to cytomegalovirus (CMV), a common but typically harmless virus that most people are infected with at some point in their lives.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup